CEBPA Methylation as a Prognostic Biomarker in Adult Patients with De Novo AML.

被引：0
|
作者：
Chen, Hsin-Yu [1 ]
Lin, Tsung-Chin [1 ]
Chou, Wen-Chien [1 ]
Hou, Hsin-An [1 ]
Tien, Hwei-Fang [1 ]
Lin, Liang-In [1 ]
机构：
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：628 / 628
页数：1
相关论文
共 50 条
  • [31] HOX expression patterns identify major cytogenetic groups and are of prognostic importance in adult AML.
    Andreeff, Michael
    Ruvolo, Vivian
    Gadgil, Sharvari
    Chen, Wenjing
    Coombes, Kevin
    Zeng, Chan
    Baron, Anna
    Drabkin, Harry
    BLOOD, 2006, 108 (11) : 635A - 635A
  • [32] Methylation profiling of hypomethylating agent response and treatment failure in pediatric and young adult MDS/AML.
    Jones, LaQuita Marie
    O'Brian, Maureen Megan
    Breese, Erin Haag
    Absalon, Michael
    Burns, Karen Cristly
    Grimley, Micheal
    Mizukawa, Benjamin
    Lee, Lynn Hua
    Perentesis, John Peter
    Phillips, Christine L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)
    Maria J. Carnicer
    Adriana Lasa
    Marcus Buschbeck
    Elena Serrano
    Maite Carricondo
    Salut Brunet
    Anna Aventin
    Jorge Sierra
    Luciano Di Croce
    Josep F. Nomdedeu
    Annals of Hematology, 2008, 87 : 819 - 827
  • [34] K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML)
    Carnicer, Maria J.
    Lasa, Adriana
    Buschbeck, Marcus
    Serrano, Elena
    Carricondo, Maite
    Brunet, Salut
    Aventin, Anna
    Sierra, Jorge
    Di Croce, Luciano
    Nomdedeu, Josep F.
    ANNALS OF HEMATOLOGY, 2008, 87 (10) : 819 - 827
  • [35] Telomere length is an independent prognostic marker in MDS but not in de novo AML
    Williams, Jenna
    Heppel, Nicole H.
    Britt-Compton, Bethan
    Grimstead, Julia W.
    Jones, Rhiannon E.
    Tauro, Sudhir
    Bowen, David T.
    Knapper, Steven
    Groves, Michael
    Hills, Robert K.
    Pepper, Chris
    Baird, Duncan M.
    Fegan, Chris
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (02) : 240 - 249
  • [36] Gain-of-function WASP mutations in pediatric and adult patients with myelodysplasia or AML.
    Beel, Karolien
    Schollen, Els
    Uyttebroeck, An
    Verhoef, Gregor
    Demuynck, Hilde
    Devriendt, Koen
    Vandenberghe, Peter
    BLOOD, 2006, 108 (11) : 208B - 208B
  • [37] Bcl-xl expression as an adverse prognostic factor for remission induction in adult de novo AML patients with intermediate risk cytogenetics.
    Schaich, M
    Illmer, T
    Mohr, B
    Schäkel, U
    Beck, J
    Ehninger, G
    BLOOD, 2000, 96 (11) : 197B - 197B
  • [38] THE INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF GATA2 MUTATIONS IN AML PATIENTS WITH CEBPA MUTATIONS
    Green, C.
    Hills, R.
    Burnett, A.
    Linch, D.
    Gale, R.
    HAEMATOLOGICA, 2012, 97 : 217 - 217
  • [39] Elderly patients with de novo acute myeloid leukemia (AML):: Prognostic factors in 132 cases.
    Luno, Elisa
    Sanzo, Carmen
    Jonte, Fermin
    Vicente, Jose Maria
    Carrera, Dolores
    Sole, Francesc
    Chamorro, Pablo
    Martinez, Araceli
    BLOOD, 2006, 108 (11) : 192B - 192B
  • [40] PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS
    Green, C. L.
    Koo, K. K.
    Hills, R. K.
    Burnett, A. K.
    Linch, D. C.
    Gale, R. E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 431 - 431
12345